Longeveron Inc. Class A Share Price

Longeveron Inc. Class A Share Price

NASDAQ: LGVN | Large Cap
$1.77
+$0.04 (2.60%) Last updated on 29 Oct, 2026 | 00:40 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Longeveron Inc. Class A Stock Performance

Open
$1.76
Prev. Close
$1.73
Circuit Range
N/A
Day Range
$1.74 - $1.78
Year Range
$0.48 - $7.50
Volume
1,348
Average Traded
$1.77

Longeveron Inc. Class A Share Price Today

As of 30 October 2026, Longeveron Inc. Class A's share price is $1.77. The stock opened at $1.76, compared to its previous close of $1.73. During today's trading session, Longeveron Inc. Class A's share price traded between $1.74 and $1.78, with an average price of $1.76. Over the past 52 weeks, the stock has recorded a high of $7.50 and a low of $0.48. In terms of performance, Longeveron Inc. Class A's share price has risen by 107.12% over the last six months and is up 113.86% on a year-on-year basis.

Longeveron Inc. Class A Share Price Chart

Line chart of the Longeveron Inc. Class A price trend over the selected period. The price rose overall, ranging from 1.76 to 1.78, ending at 1.76.
$1.74$1.78
L
Show Current Price
H

Longeveron Inc. Class A Stock Fundamentals & Key Indicators

Market Cap
$31.20B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-7.36
Revenue (TTM)
$1.20B
Return On Equity (TTM)
-225.67%
Profit Margin
-1891.67%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
15.93%

Longeveron Inc. Class A Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.14$0.37$0.40$0.29
Net Profit-$7.22-$5.44-$4.74-$6.07
Net Profit Margin-5157.14%-1470.27%-1185.00%-2093.10%
Income ChangeN/A24.65%12.87%-28.06%

Longeveron Inc. Class A Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.22$0.71$2.39$1.20
Net Profit-$18.84-$22.21-$24.62-$22.70
Net Profit Margin-1544.26%-3128.17%-1030.13%-1891.67%
Income ChangeN/A-17.89%-10.85%7.80%

About Longeveron Inc. Class A

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Longeveron Inc. Class A Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$2.61
$1.77
-33.27%
Sep 2026
$6.69
$2.66
-61.00%
Aug 2026
$0.74
$6.82
+827.89%
Jul 2026
$0.78
$0.73
+5.76%
Jun 2026
$0.77
$0.69
-9.86%
May 2026
$0.85
$0.77
-10.04%
Apr 2026
$1.03
$0.86
-14.47%
Mar 2026
$0.52
$1.00
+85.56%
Feb 2026
$0.53
$0.54
-5.26%
Jan 2026
$0.55
$0.57
+13.55%
Dec 2025
$0.68
$0.50
-24.05%
Nov 2025
$0.82
$0.66
-20.36%

LGVN Share Price FAQs